Physician profile
Michel Apoj
NPI 1689133928
$4,695.35
in general payments reported to CMS, 2019-2025
21 companies · $2,559 in 2025
The $2,559 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.46 · 2024: $2,100 · 2025: $2,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,289 · Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,288.99 |
| Food and Beverage | $1,369.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2024-2025 | |
| Janssen Biotech, INC. | $259.48 | 2024-2025 | Erleada |
| Accord Healthcare, INC. | $209.51 | 2025 | |
| Astellas Pharma US INC | $198.99 | 2024 | |
| Teleflex LLC | $172.20 | 2024-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $112.72 | 2022-2025 | Rezum Generator, Bulkamid |
| Abbvie INC. | $106.06 | 2024-2025 | |
| Endo USA, INC. | $85.80 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $83.87 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $75.24 | 2025 | Orgovyx |
| Urogen Pharma, INC. | $62.17 | 2024 | |
| Tolmar, INC. | $58.54 | 2025 | Jatenzo |
| Merck Sharp & Dohme LLC | $58.40 | 2025 | Keytruda |
| Civco Medical Instruments | $39.29 | 2025 | |
| Medtronic, INC. | $35.50 | 2024-2025 | Interstim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $32.91 | 2024 | |
| Conmed Corporation | $24.08 | 2025 | Airseal |
| Laborie Medical Technologies Corp. | $23.18 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $19.74 | 2025 | Xyosted |
| Verity Pharmaceuticals INC. | $18.95 | 2024 | Trelstar |
| Coloplast Corp | $18.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Apoj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.